AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

AMLODIPINE BESILATE+IRBESARTAN

14 registrations across 2 African markets— 10 active

Markets with AMLODIPINE BESILATE+IRBESARTAN

Recent registrations

Brand / ProductMarketHolderStatusExpires
APROVASC 5MG/300MG TABLETS🇬🇭GhanaactiveNov 2026
APROVASC TABLETS (Each tablet contains Amlodipine besilate/ Irbesartan 10mg + 300mg)🇬🇭GhanaactiveNov 2026
APROVASC TABLETS (Each film-coated tablet contains Amlodipine besilate/ Irbesartan 10mg + 150mg)🇬🇭GhanaactiveNov 2026
APROVASC TABLETS🇬🇭GhanaactiveNov 2026
APROVASC 5MG/300MG TABLETS🇬🇭GhanaactiveNov 2026
APROVASC TABLETS (Each tablet contains Amlodipine besilate/ Irbesartan 10mg + 300mg)🇬🇭GhanaactiveNov 2026
APROVASC TABLETS (Each film-coated tablet contains Amlodipine besilate/ Irbesartan 5mg + 150mg)🇬🇭GhanaactiveNov 2026
APROVASC TABLETS🇬🇭GhanaactiveNov 2026
APROVASC TABLETS (Each film-coated tablet contains Amlodipine besilate/ Irbesartan 5mg + 150mg)🇬🇭GhanaactiveNov 2026
APROVASC TABLETS (Each film-coated tablet contains Amlodipine besilate/ Irbesartan 10mg + 150mg)🇬🇭GhanaactiveNov 2026
APROVASC 300MG/5MG COMPRIME BOITE DE 28🇨🇮Côte d'IvoireSANOFI-AVENTIS DE MEXICO S.A.expiredJul 2023
APROVASC 5MG/150MG COMPRIME BOITE DE 28🇨🇮Côte d'IvoireSANOFI-AVENTIS DE MEXICO S.A.expiredJul 2023
APROVASC 150MG/10MG COMPRIME BOITE DE 28🇨🇮Côte d'IvoireSANOFI-AVENTIS DE MEXICO S.A.expiredJul 2023
APROVASC 300MG/10MG COMPRIME BOITE DE 28🇨🇮Côte d'IvoireSANOFI-AVENTIS DE MEXICO S.A.expiredJul 2023

AMLODIPINE BESILATE+IRBESARTAN in Africa — Regulatory Overview

AMLODIPINE BESILATE+IRBESARTAN is registered across 2 African markets with 14 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Côte d'Ivoire. AfricaRegulatory refreshes this data daily from official government sources.

Of the 14 registrations, 10 (71%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.